Article info

Download PDFPDF

Original research
Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome

Authors

  • Gwenny M Verstappen Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Liseth de Wolff Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Suzanne Arends Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Hella-Marie Heiermann Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Yannick van Sleen Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Annie Visser Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Janneke H Terpstra Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Dimitri A Diavatopoulos Radboud Centre for Infectious Diseases, Radboud University Medical Centre Nijmegen, Nijmegen, The NetherlandsLaboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Marieke van der Heiden Medical Microbiology and Infection Prevention, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Arjan Vissink Oral and Maxillofacial Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Debbie van Baarle Medical Microbiology and Infection Prevention, University of Groningen, University Medical Centre Groningen, Groningen, The NetherlandsCentre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands PubMed articlesGoogle scholar articles
  • Frans G M Kroese Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Hendrika Bootsma Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Hendrika Bootsma; h.bootsma{at}umcg.nl
View Full Text

Citation

Verstappen GM, de Wolff L, Arends S, et al
Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome

Publication history

  • Received February 3, 2022
  • Accepted March 21, 2022
  • First published April 12, 2022.
Online issue publication 
April 12, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.